Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective

Chemotherapy-induced nausea and vomiting (CINV) is often ranked by patients as one of the most distressing and feared consequences of chemotherapy. The novel neurokinin-1 (NK(1)) receptor antagonist fosnetupitant, a phosphorylated prodrug formulation of netupitant, was approved in Japan in 2022. Fos...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Masakazu, Iihara, Hirotoshi, Aogi, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129973/
https://www.ncbi.nlm.nih.gov/pubmed/36884027
http://dx.doi.org/10.1007/s12325-023-02474-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129973/
https://www.ncbi.nlm.nih.gov/pubmed/36884027
http://dx.doi.org/10.1007/s12325-023-02474-5

Ejemplares similares